Medical News

RSS

Researchers generate bioengineered human liver organoid using bioscaffold

Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.

1 Nov 2010

Gilead presents Phase IIa data for HCV therapy at The Liver Meeting 2010

Gilead Sciences, Inc. today announced data from a Phase IIa study showing that its investigational compounds GS 9190 and GS 9256, used in conjunction with current standard of care therapies, produced substantial suppression of the hepatitis C virus (HCV) within 28 days of treatment.

1 Nov 2010

Gottlieb Hospital nurse raises $2,000 to fight breast cancer

Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.

1 Nov 2010

Anadys presents data of ANA598 for hepatitis C treatment at AASLD Annual Meeting

Anadys Pharmaceuticals, Inc. today announced the ANA598 data to be presented at the 61st Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston, MA.

1 Nov 2010

Xstrahl launches new control system for X-ray therapy

Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.

From Xstrahl 1 Nov 2010

Health politics: Some Dems Who Voted For Law Struggling; GOP's Post-Election Strategy

USA Today reports that President Obama is spending the weekend wrapping up what he himself calls a bruising campaign season. The president, trying to stave off Democratic losses in the U.S. House and Senate, hits three cities today to urge voters to stick with his health care, energy, and economic recovery plans.

1 Nov 2010

FDA new approvals, antibiotic and neurological drugs

Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.

31 Oct 2010

‘Off the shelf’ new livers from stem cells, glimmer of hope

A researcher team has successfully produced a small-scale version of a human liver in the laboratory using stem cells. This could be a boon for patients waiting for liver transplants although it will take years to perfect the procedure say researchers.

31 Oct 2010

Killer malaria to disappear in 10-15 years: Experts

From data gathered around the world experts predict that the deadliest type of malaria can be eradicated in 10 to 15 years. The disease affects half the global population and kills an estimated 1.2 million people worldwide every year. The organism responsible for deaths is commonly Plasmodium falciparum. The parasite is at its most deadly in sub-Saharan Africa, where 90 per cent of malaria fatalities occur.

31 Oct 2010

NHS trust is compensating the bereaved and victims for poor patient care

Britain’s NHS is paying out hundreds of thousands of pounds in compensation to bereaved relatives and victims after failing in patient care. An independent inquiry found earlier this year that the Stafford hospital routinely neglected patients and displayed systemic failings.

31 Oct 2010

Proteins to punch holes in cancer cells to kill them: Study

In a medical breakthrough scientists have found a protein called perforin that kills rogue cells in the human body especially the ones causing cancer. The team comprising of experts from Melbourne and London found that perforin punches holes and kills these cells. The research appeared in the acclaimed journal Nature.

31 Oct 2010

The Cryogenic Institute of New England, Inc. completes transition to new facility

The Cryogenic Institute of New England, Inc. is pleased to announce the completed transition to 78 Chilmark Street, Worcester, MA 01604. The new facility is located just off of Shrewsbury Street in Worcester. The new facility boasts nearly 5,000 square feet of total area, allowing the Cryogenic Institute to expand its operations.

31 Oct 2010

2010 Mid-Atlantic Bio a great kick-off for hosting 2011 BIO International Convention

The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).

30 Oct 2010

Author of The Sedona Method releases new video on political atmosphere

Hale Dwoskin, author of The Sedona Method: Your Key to Lasting Happiness, Success, Peace and Emotional Well-being, has released a new video. This video, entitled "Highest and Best Good for the Planet," tackles the question of what if we simply stopped the fighting, both in everyday lives and in the all-too-often combative political atmosphere.

30 Oct 2010

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Dr. Richard Merkin, High Desert Medical Group and Heritage Health Care hosted over four thousand seniors at their 20th anniversary annual Senior Expo at the Antelope Valley Fairgrounds. Seniors lined up prior to the 9:00 am start, eager to see celebrity Debbie Reynolds perform and get free health screenings and testing including bone density, cholesterol, glucose, blood pressure, body fat, dental and vision screenings and of course, seasonal flu shots.

30 Oct 2010

Neuroscientists investigate mechanism of neural activity on complex psychological phenomena

People love to speculate about differences between the sexes, and neuroscience has brought a new technology to this pastime. Brain imaging studies are published at a great rate, and some report sex differences in brain structure or patterns of neural activity.

30 Oct 2010

Phenomenon of forced marriage in Norway

Is forced marriage an immigration problem or violence against women and children? According to researcher Anja Bredal, the Norwegian authorities have not totally made up their minds.

30 Oct 2010

The Melting Pot joins St. Jude in seventh annual Thanks and Giving campaign

The Melting Pot Restaurants join St. Jude Children's Research Hospital in the seventh annual Thanks and Giving campaign from Nov. 1 - Dec. 4, to give thanks for the healthy kids in your life, and give to those who are not by donating to cancer research.

30 Oct 2010

Special issue of Ecopsychology outlines woman's self-perception and behavior

Women experience and interact with their natural surroundings in ways that differ from men. The way in which those differences affect a woman's sense of self, body image, and drive to protect and preserve the environment are explored in a thought-provoking special issue of Ecopsychology, a peer-reviewed, online journal published by Mary Ann Liebert, Inc.

30 Oct 2010

OptiNose presents sumatriptan Phase II trial results at 2nd European Headache and Migraine Trust International

OptiNose Inc. announced the results from an analysis comparing the Phase II clinical trial obtained with its novel delivery technology to that of other formulations. The analysis suggests rapid absorption rate alone may not explain the efficacy in migraines treated with sumatriptan delivered with the Company's novel bi-directional technology. The results will be presented at the 2nd European Headache and Migraine Trust International on 28th of October 2010.

30 Oct 2010

Medical News

Researchers generate bioengineered human liver organoid using bioscaffold

Gilead presents Phase IIa data for HCV therapy at The Liver Meeting 2010

Gottlieb Hospital nurse raises $2,000 to fight breast cancer

Anadys presents data of ANA598 for hepatitis C treatment at AASLD Annual Meeting

Xstrahl launches new control system for X-ray therapy

Health politics: Some Dems Who Voted For Law Struggling; GOP's Post-Election Strategy

FDA new approvals, antibiotic and neurological drugs

‘Off the shelf’ new livers from stem cells, glimmer of hope

Killer malaria to disappear in 10-15 years: Experts

NHS trust is compensating the bereaved and victims for poor patient care

Proteins to punch holes in cancer cells to kill them: Study

The Cryogenic Institute of New England, Inc. completes transition to new facility

2010 Mid-Atlantic Bio a great kick-off for hosting 2011 BIO International Convention

Author of The Sedona Method releases new video on political atmosphere

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Neuroscientists investigate mechanism of neural activity on complex psychological phenomena

Phenomenon of forced marriage in Norway

The Melting Pot joins St. Jude in seventh annual Thanks and Giving campaign

Special issue of Ecopsychology outlines woman's self-perception and behavior

OptiNose presents sumatriptan Phase II trial results at 2nd European Headache and Migraine Trust International

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News